STOCK TITAN
  1. Home
  2. News
  3. BDX

Becton Dickinson & Co. - BDX STOCK NEWS

Welcome to our dedicated news page for Becton Dickinson & Co. (Ticker: BDX), a resource for investors and traders seeking the latest updates and insights on Becton Dickinson & Co..

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Becton Dickinson & Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Becton Dickinson & Co.'s position in the market.

News
BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) to Present at 6th Annual Evercore ISI HealthCONx Conference on November 28, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
conferences
-
News
BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) announced Q4 revenue of $5.1 billion, a 6.8% increase. FY23 revenue was $19.4 billion, a 2.7% increase. FY24 guidance includes 5.75% organic revenue growth. Recent highlights include FDA clearances and industry awards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.25%
Tags
earnings
-
News
BD Board Increases Dividend for 52nd Consecutive Year
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) increases quarterly dividend by 4.4% to $0.95 per share, payable on December 29, 2023. The indicated annual dividend rate for fiscal year 2024 is $3.80 per share. BD maintains its membership in the S&P 500 Dividend Aristocrats Index for the 52nd consecutive fiscal year, reflecting confidence in long-term outlook and commitment to create value through BD 2025 strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.25%
Tags
dividends
News
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
Rhea-AI Summary
KRMD: KORU Medical Systems, Inc. appoints Ken Miller as Chief Commercial Officer, bringing 30+ years of experience in healthcare. Miller's impressive track record includes a successful stint at NASCO Healthcare and Becton Dickinson, with notable achievements in sales & marketing and global expansion. As Chief Commercial Officer, Miller will oversee global sales and marketing, and his appointment comes with two separate options to purchase 200,000 shares of the Company's common stock. KORU Medical's President and CEO, Linda Tharby, expressed confidence in Miller's ability to drive the company's growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.25%
Tags
management
-
News
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
Rhea-AI Summary
BD (Becton, Dickinson and Company) has launched a new needle-free blood draw technology called PIVO™ Pro, which is compatible with integrated and long peripheral IV catheters. This expands on the current PIVO™ compatibility with traditional short peripheral IV catheters. The new solution allows for high-quality blood samples to be drawn directly from a patient's peripheral IV line, reducing the need for additional needlesticks. With over 60 percent of the adult population experiencing needle phobia, this solution aims to improve the patient experience by alleviating fear and anxiety associated with repetitive needlesticks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
none
-
News
BD Named Among the 100 Best Corporate Citizens of 2023
Rhea-AI Summary
BD ranks second in the healthcare equipment and services industry on the 100 Best Corporate Citizens List by 3BL.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
none
News
BD Names Greg Rodetis as Senior Vice President of Investor Relations
Rhea-AI Summary
BD announces Greg Rodetis as head of investor relations
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
none
-
News
BD, Casella Complete Industry-First Pilot Recycling 40,000 Pounds of Used Medical Devices
Rhea-AI Summary
All Used Injection Devices Recycled; Next Stage of Pilot to Expand Regionally, Add Medical Devices
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
none
-
News
BD to Announce Fiscal 2023 Fourth Quarter and Full Year Financial Results
Rhea-AI Summary
BD (Becton, Dickinson and Company) will report its fiscal 2023 Q4 and full year financial results on November 9, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
earnings
News
Azenta Announces CFO Transition
Rhea-AI Summary
Azenta announces new CFO and reaffirms guidance for Q4 fiscal 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
Stock BDX logo
Becton Dickinson & Co.

NYSE:BDX

BDX Rankings

#189 Ranked by Market Cap
#1535 Ranked by Stock Gains
#1547 Ranked by Dividends

BDX Stock Data

66.74B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Franklin Lakes

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.